Evidence map›Paper›PMID 30514054›Full record

ArticleBiomolecules & therapeutics2019

Epicatechin Prevents Methamphetamine-Induced Neuronal Cell Death via Inhibition of ER Stress.

Youra Kang, Ji-Ha Lee, Young Ho Seo, Jung-Hee Jang, Chul-Ho Jeong, Sooyeun Lee, Gil-Saeng Jeong, Byoungduck Park

Abstract read
In one paragraph

Article in Biomolecules & therapeutics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 28 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Rhinacanthin-C but Not -D Extracted fromPharmaceuticals (Basel, Switzerland) · 2022
    Article
  9. Article
  10. Antioxidants (Basel, Switzerland) · 2021
    Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Nutrients · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Youra KangCollege of Pharmacy, Keimyung University, Daegu 42601, Republic of Korea.
Ji-Ha LeeCollege of Pharmacy, Keimyung University, Daegu 42601, Republic of Korea.
Young Ho SeoCollege of Pharmacy, Keimyung University, Daegu 42601, Republic of Korea.
Jung-Hee JangDepartment of Pharmacology, School of Medicine, Keimyung University, Daegu 42601, Republic of Korea.
Chul-Ho JeongCollege of Pharmacy, Keimyung University, Daegu 42601, Republic of Korea.
Sooyeun LeeCollege of Pharmacy, Keimyung University, Daegu 42601, Republic of Korea.
Gil-Saeng JeongCollege of Pharmacy, Keimyung University, Daegu 42601, Republic of Korea.
Byoungduck ParkCollege of Pharmacy, Keimyung University, Daegu 42601, Republic of Korea.
Keimyung University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Methamphetamine (METH) acts strongly on the nervous system and damages neurons and is known to cause neurodegenerative diseases such as Alzheimer's and Parkinson's. Flavonoids, polyphenolic compounds present in green tea, red wine and several fruits exhibit antioxidant properties that protect neurons from oxidative damage and promote neuronal survival. Especially, epicatechin (EC) is a powerful flavonoid with antibacterial, antiviral, antitumor and antimutagenic effects as well as antioxidant effects. We therefore investigated whether EC could prevent METH-induced neurotoxicity using HT22 hippocampal neuronal cells. EC reduced METH-induced cell death of HT22 cells. In addition, we observed that EC abrogated the activation of ERK, p38 and inhibited the expression of CHOP and DR4. EC also reduced METH-induced ROS accumulation and MMP. These results suggest that EC may protect HT22 hippocampal neurons against METH-induced cell death by reducing ER stress and mitochondrial damage.

Indexed as

EpicatechinMethamphetamineNeuroprotection

Identifiers

PMID30514054
PMCPMC6430228
OpenAlexW2902970784

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.